Vivo Capital, LLC Essa Pharma Inc. Transaction History

Vivo Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$6.18 - $14.44 $4.6 Million - $10.7 Million	-744,058 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$7.8 - $14.38 $2.43 Million - $4.49 Million	-312,009 Reduced 29.54%	744,058 $10.6 Million
Q3 2021 Nov 15, 2021	SELL	$7.76 - $29.37 $3.85 Million - $14.6 Million	-495,613 Reduced 31.94%	1,056,067 $8.45 Million
Q2 2021 Aug 16, 2021	SELL	$24.17 - $34.28 $12.5 Million - $17.7 Million	-517,227 Reduced 25.0%	1,551,680 $44.3 Million
Q1 2021 May 17, 2021	BUY	$11.61 - $32.08 $2.03 Million - $5.61 Million	175,000 Added 9.24%	2,068,907 $60.1 Million
Q4 2020 Feb 16, 2021	BUY	$5.47 - $12.1 $2.06 Million - $4.56 Million	377,042 Added 24.86%	1,893,907 $22.6 Million
Q3 2020 Nov 13, 2020	BUY	$6.0 - $7.79 $9.1 Million - $11.8 Million	1,516,865 New	1,516,865 $10.5 Million

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $72.3M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.